Figure 1
From: Endotoxin and CD14 in the progression of biliary atresia
Plasma sCD14 levels in patients with BA. Quantitative analysis of soluble CD14 by ELISA in the plasma of 41 patients with early-stage biliary atresia (BA), 25 patients followed-up at the outpatient department (OPD) post-Kasai, 49 patients with late-stage BA, 9 patients with choledochal cysts (CC), and 7 healthy controls. Data represent the mean ± SD from duplicate experiments. Statistical differences were tested by nonparametric Wilcoxon matched-pairs test. *p < 0.05 and **p < 0.01 vs. late-stage BA.